ArTisaN Trial Protocol: A Single Centre, Open-Label, Phase II Trial of the Safety and Efficacy of TheraSphere Selective Internal Radiation Therapy (SIRT) in the Treatment of Inoperable Metastatic (liver) Neuroendocrine Neoplasia (NENs)

ArTisaN Trial Protocol: A Single Centre, Open-Label, Phase II Trial of the Safety and Efficacy of TheraSphere Selective Internal Radiation Therapy (SIRT) in the Treatment of Inoperable Metastatic (liver) Neuroendocrine Neoplasia (NENs)

header-info

We describe the design and rationale of ArtTisaN, a phase II study to assess efficacy and tolerability of SIRT using TheraSpheres for the management of liver metastases secondary to NENs.